arrow_back Back to App

Fair Pharmacy Assessment and Transparency in Medicare Part D

New rules aim to ensure pharmacies are evaluated more fairly under Medicare Part D, potentially impacting service quality and drug access. They also introduce greater transparency in billing between pharmacies and insurers, which could help in better understanding drug costs.
Key points
Standardized rules for assessing pharmacy performance and quality in Medicare Part D will be implemented from 2025, aiming for fairer conditions for all pharmacies.
Increased transparency in pharmacy payments: insurers will be required to promptly provide pharmacies with detailed billing information for drugs, including fees and discounts.
The Office of the Inspector General will conduct a study on current pharmacy assessment and billing systems to identify issues and recommend improvements.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_5393
Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
Process start date: 2023-09-12
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_5393.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-12.

What are the main provisions?

Key points include:

  • Standardized rules for assessing pharmacy performance and quality in Medicare Part D will be implemented from 2025, aiming for fairer conditions for all pharmacies.
  • Increased transparency in pharmacy payments: insurers will be required to promptly provide pharmacies with detailed billing information for drugs, including fees and discounts.
  • The Office of the Inspector General will conduct a study on current pharmacy assessment and billing systems to identify issues and recommend improvements.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Griffith, H. Morgan [R-VA-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Benefits